Effect of medical Qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: A randomized controlled trial

Supportive Care in Cancer

Volumn 20, Issue 6, 2012, Pages 1235-1242

  Oh, Byeongsang ^a,b,c   Butow, Phyllis N ^b   Mullan, Barbara A ^b   Clarke, Stephen J ^a,c   Beale, Philip J ^a,c   Pavlakis, Nick ^c   Lee, Myeong Soo ^d   Rosenthal, David S ^e   Larkey, Linda ^f   Vardy, Janette ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

^d Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^e HARVARD MEDICAL SCHOOL   (United States)

^f ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Cancer; Cognitive function; Inflammation; Medical Qigong; Quality of life

Indexed keywords

ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; COGNITIVE DEFECT; COLORECTAL CANCER; CONTROLLED STUDY; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER COGNITIVE FUNCTION; FEMALE; FUNCTIONAL ASSESSMENT OF CANCER THERAPY GENERAL; HUMAN; INFLAMMATION; KINESIOTHERAPY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL QIGONG; MEDITATION; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; PSYCHOLOGIC TEST; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; STOMACH CANCER; THERAPY EFFECT; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BREATHING EXERCISES; C-REACTIVE PROTEIN; COGNITION DISORDERS; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NEOPLASMS; QUALITY OF LIFE;

EID: 84863981571     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-011-1209-6     Document Type: Article

References (40)

1. Vardy J, Wefel JS, Ahles T et al (2008) Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 19(4):623-629 (Pubitemid 351461030)
2. Jenkins V (2006) A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 94:828-834
3. Shilling V, Jenkins V (2007) Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. Eur J Oncol Nurs 11(1):6-15
4. Boykoff N, Moieni M, Subramanian S (2009) Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response. J Cancer Surviv 3(4):223-232
5. Vardy J, Rourke S, Tannock I (2007) Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. J Clin Oncol 25 (17):2455
6. Schagen SB (1999) Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85:640-650 (Pubitemid 29075285)
7. van Dam FS (1998) Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90:210-218 (Pubitemid 28114539)
8. Castellon SA (2004) Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 26:955-969 (Pubitemid 39577316)
9. Ahles TA (2002) Neuropsychological impact of standard-dose chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20:485-493 (Pubitemid 34072533)
10. Vardy J, Xu W, Booth C et al (2008) Relation between perceived cognitive function and neuropsychological performance in survivors of breast and colorectal cancer. ASCO Meeting Abstracts, p 9520
11. Schagen SB, Muller MJ, Boogerd W et al (2006) Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. J Natl Cancer Inst 98(23):1742-1745 (Pubitemid 44942713)
12. Wefel J, Lenzi R, Theriault R et al (2004) Chemobrain in breast carcinoma? A prologue. Cancer 101(3):466-475
13. Von Ah D, Harvison KW, Monahan PO et al (2009) Cognitive function in breast cancer survivors compared to healthy age- and education-matched women. Clin Neuropsychol 23(4):661-674
14. Fan HGM, Houede-Tchen N, Yi Q-L et al (2005) Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol 23(31):8025-8032 (Pubitemid 46657404)
15. Vardy J (2009) Cognitive function in survivors of cancer. ASCO Educational Book 2009(1):570-574
16. Roberts RO, Geda YE, Knopman DS et al (2010) Metabolic syndrome, inflammation, and nonamnestic mild cognitive impairment in older persons: a population-based study. Alzheimer Dis Assoc Disord 24(1):11-18. doi:10.1097/WAD.0b013e3181a4485c
17. Seruga B, Zhang H, Bernstein L et al (2008) Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer 8(11):887-899
18. Onem Y, Terekeci H, Kucukardali Y et al (2010) Albumin, hemoglobin, body mass index, cognitive and functional performance in elderly persons living in nursing homes. Arch Gerontol Geriatr 50(1):56-59
19. Seeman TE, McEwen BS, Singer BH et al (1997) Increase in urinary cortisol excretion and memory declines: MacArthur studies of successful aging. J Clin Endocrinol Metab 82 (8):2458-2465 (Pubitemid 27337857)
20. Jim H, Small B, Patterson S et al (2010) Cognitive impairment in men treated with luteinizing hormone-releasing hormone agonists for prostate cancer: a controlled comparison. Supportive Care Cancer 18(1):21-27. doi:10.1007/s00520-009-0625-3
21. Ahles TA, Saykin AJ, Noll WW et al (2003) The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psychooncology 12(6):612-619 (Pubitemid 37086736)
22. Ahles TA, Saykin AJ (2007) Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7 (3):192-201
23. Silverman D, Dy C, Castellon S et al (2007) Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res Treat 103(3):303-311 (Pubitemid 46944511)
24. Oh B, Butow P, Mullan B et al (2009) Impact of medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial. Ann Oncol 21:608-614
25. Kemoun G, Thibaud M, Roumagne N et al (2010) Effects of a physical training programme on cognitive function and walking efficiency in elderly persons with dementia. Dement Geriatr Cogn Disord 29(2):109-114
26. Etnier J, Johnston R, Dagenbach D et al (1999) The relationships among pulmonary function, aerobic fitness, and cognitive functioning in older COPD patients*. Chest 116(4):953-960 (Pubitemid 29491865)
27. Colcombe AM, Kramer AF, Irwin DE et al (2003) Age-related effects of attentional and oculomotor capture by onsets and color singletons as a function of experience. Acta Psychologica 113 (2):205-225 (Pubitemid 36881086)
28. Lautenschlager NT, Cox KL, Flicker L et al (2008) Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA 300(9):1027-1037
29. Heikkila K, Ebrahim S, Rumley A et al (2007) Associations of circulating C-reactive protein and interleukin-6 with survival in women with and without cancer: findings from the British Women's Heart and Health Study. Cancer Epidemiol Biomarkers Prev 16(6):1155-1159 (Pubitemid 46984952)
30. Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365-376 (Pubitemid 23073154)
31. Jacobs SR, Jacobsen PB, Booth-Jones M et al (2007) Evaluation of the functional assessment of cancer therapy cognitive scale with hematopoetic stem cell transplant patients. J Pain Symptom Manag 33(1):13-23 (Pubitemid 46017075)
32. Wagner L, Sweet J, Butt Z et al (2009) Measuring patient selfreported cognitive function: development of the Functional Assessment of Cancer Therapy - Cognitive Function instrument. J Support Oncol 7(6):W32-W39
33. Cella DF, Tulsky DS, Gray G et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570-579 (Pubitemid 23071057)
34. Hwang SS, Chang VT, Kasimis BS et al (2003) A comparison of three fatigue measures in veterans with cancer. Cancer Investigation 21(3):363-373 (Pubitemid 37055668)
35. Carlson LE, Speca M, Patel KD et al (2004) Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology 29(4):448-474 (Pubitemid 38121602)
36. Mutrie N, Campbell AM, Whyte F et al (2007) Benefits of supervised group exercise programme for women being treated for early stage breast cancer: pragmatic randomised controlled trial. BMJ 334(7592):517
37. Pierce BL, Ballard-Barbash R, Bernstein L et al (2009) Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 27(21):3437-3444
38. Noble JM, Manly JJ, Schupf N et al (2010) Association of Creactive protein with cognitive impairment. Arch Neurol 67 (1):87-92
39. Yeh M, Lee T, Chen H et al (2006) The influences of Chan-Chuang Qi-gong therapy on complete blood cell counts in breast cancer patients treated with chemotherapy. Cancer Nurs 29 (2):149-155 (Pubitemid 44305242)
40. Luo S, Tong T (1988) Effect of vital gate Qigong exercise on malignant tumor. First World Conference for Academic Exchange of Medical Qigong, Beijing, p 122